XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net income $ 133,218 $ 45,139
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Gain on strategic investments and marketable securities, net (97,419) (15,570)
Stock-based compensation 75,115 34,350
Gain on remeasurement of previously held minority interest, net (42,292)  
Deferred income taxes 20,670 (9,660)
Depreciation and amortization 11,564 6,689
Bond amortization (4,990) (3,890)
Noncash lease expense 1,795 1,395
Amortization of debt issuance cost 782 756
Unrecognized tax benefits 544 855
Other noncash items 461 1,047
Change in assets and liabilities:    
Accounts and notes receivable and contract assets (51,132) (50,431)
Inventory (710) (15,811)
Prepaid expenses and other assets 2 (64,348)
Accounts payable, accrued and other liabilities (84,289) (37,043)
Deferred revenue 20,743 50,199
Net cash used in operating activities (15,938) (56,323)
Cash flows from investing activities:    
Purchases of investments (241,457) (145,124)
Proceeds from call, maturity, and sale of investments 330,472 81,088
Purchases of property and equipment (16,194) (8,513)
Proceeds from disposal of property and equipment 34  
Purchases of intangible assets   (125)
Strategic investments (9,128)  
Business acquisition, net of cash acquired (237,771)  
Net cash used in investing activities (174,044) (72,674)
Cash flows from financing activities:    
Net proceeds from equity offering   33,650
Proceeds from options exercised   39,181
Income and payroll tax payments for net-settled stock awards (2,710) (34,841)
Net cash provided by (used in) financing activities (2,710) 37,990
Effect of exchange rate changes on cash and cash equivalents (1,978) 779
Net decrease in cash and cash equivalents (194,670) (90,228)
Cash and cash equivalents and restricted cash, beginning of period 600,670 355,552
Cash and cash equivalents and restricted cash, end of period $ 406,000 $ 265,324